✦ LIBER ✦

The neurochemical mechanism of rebound psychosis in Parkinson's disease

✍ Scribed by Spiridon Papapetropoulos; Deborah C. Mash

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 35 KB
Volume: 20
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20438

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A reply to this letter has been published in Movement DisordersMov Disord (2005) 20 (4) 515.

📜 SIMILAR VOLUMES

Reply: Rebound psychosis in Parkinson's

Reply: Rebound psychosis in Parkinson's disease

✍ Hubert H. Fernandez; Michael S. Okun 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 1 views

## Abstract The original letter to which this reply refers was published in __Movement__ DisordersMov Disord (2005) 20 (4) 515.

Rebound psychosis: Effect of discontinua

Rebound psychosis: Effect of discontinuation of antipsychotics in Parkinson's disease

✍ Hubert H. Fernandez; Martha E. Trieschmann; Michael S. Okun 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

## Abstract To determine whether psychiatrically stable patients with a history of drug‐induced psychosis could be successfully weaned off their antipsychotic drug, we offered consecutive Parkinson disease (PD) patients on quetiapine or clozapine, who were free of any on‐going psychosis, to be slow

Quetiapine for the treatment of drug-ind

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

✍ Hubert H. Fernandez; Joseph H. Friedman; Carol Jacques; Michael Rosenfeld 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 2 views

Atypical antipsychotics in the treatment

Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease

✍ Joseph H. Friedman; Stewart A. Factor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Estimate of point prevalence of Parkinso

Estimate of point prevalence of Parkinson's disease induced psychosis in the United States

✍ Robert J. Holt 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

s disease (HD) is a fatal neurodegenerative disorder, which usually manifests in middle age with motor, psychiatric and/or cognitive disturbances. In his recent review, Francis Walker stated that medical treatment of HD has made little progress in the past 20 years. 1 Despite a large number of repor

Performance of the scale for assessment

Performance of the scale for assessment of positive symptoms in Parkinson's disease psychosis

✍ Tiffini S. Voss; Alicia F.D. Brocht; Bernard Ravina 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 1 views

Lerner and Bagic 1 have to be congratulated for their hypothesis on PD pathogenesis. They suggest that the sequence of the brain changes in PD follows specific and repeatable patterns in all cases, as well as that a prion-like process underlies neurodegeneration. These ideas could explain several fe